# Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy

> **NCT05992610** · NA · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 40 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Oral Cavity
- Pharynx Carcinoma
- Larynx Carcinoma
- Paranasal Sinus Carcinoma

## Interventions

- **OTHER:** Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy

## Key facts

- **NCT ID:** NCT05992610
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-17
- **Primary completion:** 2025-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992610, "Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05992610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*